Fatty liver. A health problem in type 2 diabetic patients?

Aleksandra Szymborska-Kajanek; Marta Wróbel; Krzysztof Strojek

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

4/2007
vol. 10

Send email

Copy url:

abstract:

Fatty liver. A health problem in type 2 diabetic patients?

Aleksandra Szymborska-Kajanek

,

Marta Wróbel

,

Krzysztof Strojek

Przew Lek 2007; 4: 36-42

Online publish date: 2007/07/09

View full text Get citation

Liver function tests are commonly used in clinical practice to screen for liver disease, monitor the progression of known disease, and monitor the effects of potentially hepatotoxic drugs. Fatty liver, regardless of cause, can lead to cirrhosis and can be an important cause of morbidity and mortality. The most common cause of abnormal liver function tests in type 2 diabetic patients is nonalcoholic fatty liver disease (NAFLD). It is frequently associated with visceral obesity, dyslipidaemia and insulin resistance, and represents another component of the metabolic syndrome. This article will provide a review of the definition, clinical symptoms and pathology of NAFLD, and drug therapy related to type 2 diabetic patients.

keywords:

Fatty liver. A health problem in type 2 diabetic patients?

Aleksandra Szymborska-Kajanek , Marta Wróbel , Krzysztof Strojek

diabetes mellitus, fatty liver, NAFLD, hypoglycaemic agents

Aleksandra Szymborska-Kajanek

,

Marta Wróbel

,

Krzysztof Strojek